Change of Broker

Change of Broker

Ovoca Bio PLC

13 November 2025

Ovoca Bio PLC

13 November 2025

Ovoca Bio plc

("Ovoca" or the "Company")

Change of Broker

Dublin, Ireland, 13 November 2025 ‐ Ovoca Bio Plc announces, in anticipation of completion of the acquisition of Tadeen International Limited as originally announced on 7 May 2025, the appointment of CMC Markets UK Plc, trading as CMC CapX, as broker to the Company with immediate effect. Beaumont Cornish Limited will continue to act as the Company's Nominated Adviser.

End

For further information:

Ovoca Bio plc

Tim McCutcheon (Chief Executive Officer)

Tel +353 1 661 9819

info@ovocabio.com

Beaumont Cornish Limited (Nominated Adviser)

James Biddle / Roland Cornish

Tel: +44 (0) 207 628 3396

CMC Markets UK Plc (Broker)

Douglas Crippen

Tel: +44 (0) 20 3003 8632

Nominated Adviser Statement

Beaumont Cornish Limited ("Beaumont Cornish"), is the Company's Nominated Adviser and is authorised and regulated in the United Kingdom by the Financial Conduct Authority. Beaumont Cornish's responsibilities as the Company's Nominated Adviser, including a responsibility to advise and guide the Company on its responsibilities under the AIM Rules for Companies and AIM Rules for Nominated Advisers, are owed solely to the London Stock Exchange. Beaumont Cornish is not acting for and will not be responsible to any other person for providing the protections afforded to customers of Beaumont Cornish nor for advising them in relation to the transaction and arrangements described in the announcement or any matter referred to in it.